Genomics is increasingly being adopted into both research and clinical settings. Here, we speak to Dyann Wirth about the use of genomics in the field of malaria, from what it can uncover about the parasite to the hurdles that need to be overcome moving towards elimination.
Browsing: Host-pathogen Interaction
A study by a team of researchers demonstrates that the commonly known food poisoning pathogen E.coli is integral in promoting health by producing a compound which helps cells absorb iron.
A new study has revealed gender-specific differences in infection and in antibiotic resistance genes during N. gonorrhoeae infection.
New research by NIH-funded scientists has revealed evidence that viral species, particularly herpesviruses, could contribute toward the complex biology underlying Alzheimer’s disease.
Take a look behind the scenes of a recent Future Virology review entitled ‘Antiviral therapeutic approaches for human rhinovirus infections’ as we ask author Peter Barlow about antivirals, antibodies and the host response.
Recent technological advancements have allowed organoids to become a viable research tool for a wide range of development and disease models. Here, we look at some of the research that’s been done in infectious diseases and delve into what the future of organoids might look like.
A recent study has revealed the metabolic pathway that bacteria use to survive in bone, which could potentially act as a target for the development of new antimicrobial compounds.
At the recent Microbiology Society Annual Conference (10–12 April, Birmingham, UK) we spoke to Mark Wass about his work on Ebolaviruses in which he’s delved into the molecular determinants of the virus’s pathogenicity.
Although the microbiome has been implicated in many pathologies, from obesity to Alzheimer’s, in this feature, we take a closer look at the role of the microbiome in infectious diseases. Discover more in our February focus.
This research, published in Future Microbiology, screens host proteins for those that interact with EspF via flow cytometry and high-throughput screening to try and shed light on how EspF affects host cells to induce colitis and even colorectal carcinogenesis.